Rayaprolu BM, Strawser JJ, Anyarambhatla G. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug Dev Ind Pharm. 2018. https://doi.org/10.1080/03639045.2018.1483392.
Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021. https://doi.org/10.1038/s41551-021-00698-w.
Martin C, Jiri D. Advances in dissolution instrumentation and their practical applications. Drug Dev Ind Pharm. 2014. https://doi.org/10.3109/03639045.2013.841184.
Kulkarni MC, Kolhe SV. Formulation development and evaluation of atorvastatin calcium tablets using co-processed excipients. Int J Pharm Sci Rev Res. 2016;36(1):217–22.
Atneriya U, Kapoor D, Sainy J, Maheshwari R. In vitro profiling of fenofibrate solid dispersion mediated tablet formulation to treat high blood cholesterol. Annales Pharma Fran. 2023. https://doi.org/10.1016/j.pharma.2022.08.009.
Sareen S, Mathew G, Joseph L. Improvement in solubility of poorly water-soluble drugs by solid dispersion. Int J Pharm Investig. 2012. https://doi.org/10.4103/2230-973X.96921.
Article PubMed PubMed Central Google Scholar
Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int J Pharm. 2005. https://doi.org/10.1016/j.ijpharm.2004.12.019.
Choi JS, Lee SE, Jang WS, Byeon JC, Park JS. Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats. Eur J Pharm Sci. 2017;106:152–8. https://doi.org/10.1016/j.ejps.2017.05.065.
Article CAS PubMed Google Scholar
Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J of Pharm Sci. 1971. https://doi.org/10.1002/jps.2600600902.
Zhao J, Koo O, Pan D, Wu Y, Morkhade D, Rana S, Saha P, Marin A. The impact of disintegrant type, surfactant, and API properties on the processability and performance of roller compacted formulations of acetaminophen and aspirin. AAPS J. 2017. https://doi.org/10.1208/s12248-017-0104-6.
Jain KK. An overview of drug delivery systems. In: Jain K, editor. Drug delivery systems. Methods in molecular biology. New York, NY: Humana; 2020. https://doi.org/10.1007/978-1-4939-9798-5_1.
Armstrong NA. Tablet manufacture by direct compression. In: Swarbrick J, editor. Encyclopaedia of Pharmaceutical Technology. 3rd ed. USA: Informa Healthcare; 2007. p. 3673–83.
Alderborn G. Tablets and compaction. In: Aulton ME, Taylor KM, editors. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. 4th ed. London: Elsevier Ltd; 2013. p. 504–49.
Augsburger LL, Zellhofer MJ. Tablet formulation. In: Encyclopaedia of pharmaceutical technology. 3rd ed. USA: Informa Healthcare; 2007. p. 3641–52.
Thoorens G, Krier F, Leclercq B, Carlin B, Evrard B. Microcrystalline cellulose, a direct compression binder in a quality by design environment- a review. Int J Pharm. 2014;473:64–72.
Article CAS PubMed Google Scholar
Li Z, Zhao L, Lin X, Shen L, Feng Y. Direct compaction: an update of materials, trouble-shooting, and application. Int J Pharm. 2017. https://doi.org/10.1016/j.ijpharm.2017.07.035.
Article PubMed PubMed Central Google Scholar
Gonnissen Y, Verhoeven E, Peeters E, Remon J, Vervaet C. Coprocessing via spray drying as a formulation platform to improve the compactibility of various drugs. Eur J Pharm and Biopharm. 2008;69:320–34.
Apeji YE, Aluga D, Olayemi OJ, Oparaeche C, Anyebe SN, Gamlen MJ, Oyi AR. Comparative analysis of co-processed starches prepared by three different methods. British J Pham. 2017. https://doi.org/10.5920/bjpharm.2017.08.
van der Merwe J, Steenekamp J, Steyn D, Hamman J. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics. 2020. https://doi.org/10.3390/pharmaceutics12050393.
Article PubMed PubMed Central Google Scholar
Crowley PJ, Martini LG. Formulation design: new drugs from old. Drug Discov Today Ther Strateg. 2004. https://doi.org/10.1016/j.ddstr.2004.11.020.
Guth F, Schiffter HA, Kolter K. Novel excipients-from concept to launch. Chim Oggi Chem Today. 2013;31:78–81.
Gohel MC, Jogani PD. A review of co-processed directly compressible excipients. Journal of Pharmacy & Pharmaceutical Sciences: a publication of the Canadian Society for Pharmaceutical Sci. 2005;8(1):76–93.
Gupta P, Nachaegari SK, Bansal AK. Improved excipient functionality by coprocessing. In: Katdare A, Chaubal M, editors. Excipient development for pharmaceutical, biotechnology and drug delivery systems. CRC Press; 2006. p. 109–26. https://doi.org/10.1201/9781420004137.
Desai U, Shavan R, Mhatre P, Chinchole R. A review: coprocessed excipients. Int J Pharm Sci Rev Research. 2012;12(2):93–105.
Rojas J, Buckner I, Kumar V. Co-processed excipients with enhanced direct compression functionality for improved tableting performance. Drug Dev Ind Pharm. 2012;38(10):1159–70.
Article CAS PubMed Google Scholar
Salim I, Kehinde OA, Abdulsamad A, Khalid GM, Gwarzo MS. Physicomechanical behavior of novel directly compressible starch-MCC-povidone composites and their application in ascorbic acid tablet formulation. British J Pharm. 2018. https://doi.org/10.5920/bjpharm.2018.03.
Saha S, Shahiwala AF. Multifunctional coprocessed excipients for improved tabletting performance Multifunctional coprocessed excipients for improved tabletting performance. Drug Delivery. 2009. https://doi.org/10.1517/17425240802708978.
Builders PF, Bonaventure AM, Tiwalade A, Okpako LC, Attama AA. Novel multifunctional pharmaceutical excipients derived from microcrystalline cellulose-starch microparticulate composites prepared by compatibilized reactive polymer blending. Int J Pharm. 2010;388:159–67.
Article CAS PubMed Google Scholar
Ozkan Y, Atay T, Dikmen N, Aboul-Enein HY. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with β-cyclodextrin. Pharm Acta Helv. 2000. https://doi.org/10.1016/s0031-6865(99)00063-1.
Harrower AD. Comparison of efficacy, secondary failure rate and complications of sulfonylurea. J Diabetes Its Complicat. 1994. https://doi.org/10.1016/1056-8727(94)90044-2.
Palmer KJ, Brogden RN. Gliclazide, an update of its pharmacological properties and therapeutic efficacy in NIDDM. Drugs. 1993. https://doi.org/10.2165/00003495-199346010-00007.
Alkhamis KA, Allaboun H, Al-Momani WY. Study of the solubilization of gliclazide by aqueous micellar solutions. J Pharm Sci. 2003. https://doi.org/10.1002/jps.10350.
Varshosaz J, Talari R, Mostafavi SA, Nokhodchi A. Dissolution enhancement of gliclazide using in situ micronization by solvent change method. Pow Tech. 2008. https://doi.org/10.1016/j.powtec.2008.02.018.
Saharan VA, Choudhury P. Dissolution rate enhancement of gliclazide by ordered mixing. Acta Pharm. 2011. https://doi.org/10.2478/v10007-011-0021-7.
Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech. 2008. https://doi.org/10.1208/s12249-008-9079-z.
Article PubMed PubMed Central Google Scholar
Paul S, Islam MN, Ali MA, Barman RK, Wahed MII, Rahman BM. Improvement of dissolution rate of gliclazide using solid dispersions with aerosil 380 and its effect on alloxan-induced diabetic rats. Pharmacology and Pharmacy. 2019. https://doi.org/10.4236/pp.2019.108030.
Biswal S, Sahoo J, Murthy PN. Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90. AAPS PharmSciTech. 2009. https://doi.org/10.1208/s12249-009-9212-7.
Article PubMed PubMed Central Google Scholar
Febriyenti F, Rahmi S, Halim A. Study of gliclazide solid dispersion systems using PVP k-30 and PEG 6000 by solvent method. J Pharm Bioallied Sci. 2019. https://doi.org/10.4103/jpbs.JPBS_87_18.
Article PubMed PubMed Central Google Scholar
Wang L, De Cui F, Sunada H. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Chem Pharm Bull. 2006. https://doi.org/10.1248/cpb.54.37.
Varma MM, Kumar PS. Formulation and evaluation of gliclazide tablets containing PVP-K30 and Hydroxy propyl-β-cyclodextrin solid dispersion. Int J Pharm Sci Nanotech. 2012;5(2):1706–19.
Fuley MJ, Parisar S. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions. Acta Pharm. 2009;59:57–65.
Dukhan AAM, Amalina N, Oo MK, Sengupta P, Doolaanea AAM, Aljapairai KAS, Chatterjee B. Formulation of dispersed gliclazide powder in polyethylene glycol–polyvinyl caprolactam–polyvinyl acetate grafted copolymer carrier for capsulation and improved dissolution. Indian J Pharm Educ Res. 2018. https://doi.org/10.5530/ijper.52.4s.100.
Mooranian A, Negrulj R, Mathavan S, et al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innov. 2014. https://doi.org/10.1007/s12247-014-9182-5.
留言 (0)